Indirect chemiluminescent immunoassay (CLIA) to test IgG antibodies against Strongyloides stercoralis in human serum/plasma.
- Excellent sensitivity (94%) and specificity (93%)
- Adapted to urgent diagnosis - Rapid, automated protocol, results in around 1h
- No sample cumulation compared to the only existing ELISA’s in the market
- Full compatibility with the VirClia portfolio +90 assays
PRODUCTS
STRONGYLOIDES STERCORALIS VIRCLIA® IgG MONOTEST
MORE RESOURCES
Downloadable PDF materials, brochures, and technical documents.
The latest insights, news, and research articles from our scientific team.
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Beyond detection: H. pylori testing in today’s laboratory workflow
Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...
Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...
